An update of the recommendations of the spanish neonatology society for the use of paivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants
Manuel Sánchez Luna,
Alejandro Pérez Muñuzuri,
José Luis Leante Castellanos,
César W. Ruiz Campillo,
Ester Sanz López,
Isabel Benavente Fernández,
María Dolores Sánchez Redondo,
Segundo Rite Gracia
Affiliations
Manuel Sánchez Luna
Hospital General Universitario Gregorio Marañón, Madrid, Spain
Alejandro Pérez Muñuzuri
Hospital Clínico Universitario, Santiago de Compostela, Spain
José Luis Leante Castellanos
Hospital General Universitario Santa Lucía, Cartagena, Spain
